Profile
Anne Johnson is currently Chief Accounting Officer at Atai Beckley, Inc. Formerly, Ms. Johnson was Corporate Controller at Chimerix, Inc., Vice President-Finance at Xanodyne Pharmaceuticals, Inc., Controller at Aruvant Sciences, Inc., and Chief Financial & Accounting Officer at Atai Beckley NV.
Ms. Johnson completed undergraduate education at The University of North Carolina at Wilmington.
Anne Johnson active positions
| Companies | Position | Start |
|---|
Former positions of Anne Johnson
| Companies | Position | End |
|---|---|---|
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Director of Finance/CFO | - |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning | Comptroller/Controller/Auditor | - |
| CHIMERIX, INC. | Comptroller/Controller/Auditor | - |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Director of Finance/CFO | - |
Education of Anne Johnson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Chimerix, Inc.
Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
The University of North Carolina at Wilmington
The University of North Carolina at Wilmington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning | Health Technology |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Anne Johnson
















